Propagermanium Induces NK Cell Maturation and Tends to Prolong Overall Survival of Patients With Refractory Cancer.
Clicks: 493
ID: 43770
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
75.0
/100
493 views
350 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #2 of 31 articles by views in Anticancer research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Propagermanium (PG) inhibits the CCL2/CCR2 axis, and has been shown to function as an immune modulator. This study investigated its anti-tumor mechanism in patients with refractory cancers.Five healthy volunteers and 23 patients with refractory oral (n=8) or gastric (n=15) cancer received PG (30 mg/day). We performed flow cytometry (FCM) of peripheral blood mononuclear cells and in vitro killing assays.FCM revealed that CD16/CD56 NK cells (i.e., mature, cytolytic subset) increased, and the apoptosis induction rate of cancer cells increased after PG administration. Among gastric cancer patients, median OS was 172.0 days. Two patients showed complete remission of lung or liver metastasis. Survival of patients with oral cancer also tended to be prolonged.PG induces NK cell maturation, and may potentiate anti-tumor activity.
| Reference Key |
kikuchi2019propagermaniumanticancer
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Kikuchi, Shojiro;Noguchi, Kazuma;Wakai, Keiko;Hamazaki, Yoko;Tozawa, Katsuyuki;Jomori, Takahito;Sasako, Mitsuru;Miwa, Hiroto; |
| Journal | Anticancer research |
| Year | 2019 |
| DOI |
10.21873/anticanres.13651
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.